IL1B and diabetes mellitus: The results showed that the levels of IL‐1β and TNF‐α in the serum samples obtained from the experimental groups increased in the diabetes group, and there was a significant decrease in both the 18β group and the silver nanoparticle‐loaded 18β group as compared to the diabetes group (Figure 5).